Top 10 Drug Delivery Technology Market cover

Top 10 Drug Delivery Technology Market by Applications (Injectable, Sustained Release, Aerosol, Transdermal, Implants, Targeted Delivery, Pegylation, Encapsulation, and Liposomal) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: MC-2531
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global top 10 drug delivery technology market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the advancement in technology for instance, micro-needle transdermal patches, and novel intelligent inhalers.

Top 10 Drug Delivery Technology Market summary

Drug delivery is a procedure of operating a compound to gain a therapeutic impact in animals and humans, these systems are built technologies for the targeted delivery. Medicines are being accustomed for better health and extending lives. This technology improves the drug life cycle by enhancing drug efficacy and safety by extending patent rights. Increasing demand for effective delivery of pharmaceutical and biopharmaceuticals with innovation in drug delivery technologies are key forces of the market expansion. Furthermore, introduction of self-administration and home-care drug delivery devices are expected to influence the market growth.

Drug delivery technology are revenue shooters as this technology improves drug life cycle and improve a competitive scope to the drug by rising drug safety. Moreover, rising applications of non-conventional drug delivery technology in transdermal, nasal, and pulmonary in diabetes and chronic conditions is expected to positively influence the market. 

Market Trends, Drivers, Restraints, and Opportunities

  • Rising demand for advanced technology to improve drug delivery and ensure safety process are key factors driving the market growth.
  • Increasing number of the aging population who are at high risks of exposing to various infectious and chronic illness present a major driver of the market.
  • Rapid expansion of the biopharmaceutical operations and improving drugs developments are major factors to boost the market growth.
  • Increasing applications of non-conventional drug delivery technology in chronic conditions is expected to fuel the market during the forecast period. 
  • Drug failures, patient expirations, and other technical barriers of using drugs delivery are expected to hamper the market growth in the coming years.

Scope of the Report                         

The report on the global top 10 drug delivery technology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Top 10 Drug Delivery Technology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentations

Applications (Injectable, Sustained Release, Aerosol, Transdermal, Implants, Targeted Delivery, Pegylation, Encapsulation, and Liposomal)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Applied Pharma Ltd.; Alkermes Inc.; Nanopass Technologies Ltd.; Altea Therapeutics Inc.; Biovail Inc.; Paradigm Inc.; Ethypharm Ltd.; Eurand Pharmaceuticals Inc.; Elan Corp.; Johnson & Johnson, Ltd.; Nektar Therapeutics Ltd.; Bioject Inc.; Penwest Pharmaceuticals; Vectura Group Plc.; Durect Corp.; Labopharm Europe Ltd.; Skye Pharma Plc ; Endo Pharmaceuticals Inc.; and Flamel Technologies Inc.

Market Segment Insights

Sustained release segment is expected to grow at a robust pace

Based on applications, the global top 10 drug delivery technology market is divided into injectable, sustained release, aerosol, transdermal, implants, targeted delivery, pegylation, encapsulation, and liposomal. The sustained release segment is expected to grow at a robust pace during the projected period owing to the enormous popularity of daily formulations for the diseases. However, the targeted delivery segment is projected to account for a key market share during the forecast period due to technology advancement and rising adoption level.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America accounted for a key share of the market in 2019 and is expected to constitute a major market share during the targeted period due to technological innovations and massive investment on ongoing researches for drug delivery methods. The market of Asia Pacific, however, is anticipated to expand at an impressive growth rate during the forecast period owing to the increasing patient awareness and rising disposable incomes of a large number of the population in the region.

Top 10 Drug Delivery Technology Market region

Segments

Segments Covered in the Report

The global top 10 drug delivery technology market has been segmented on the basis of

Applications

  • Injectable
  • Sustained Release
  • Aerosol
  • Transdermal
  • Implants
  • Targeted Delivery
  • Pegylation
  • Encapsulation
  • Liposomal

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Applied Pharma Ltd.
  • Alkermes Inc.
  • Nanopass Technologies Ltd.
  • Altea Therapeutics Inc.
  • Biovail Inc.
  • Paradigm Inc.
  • Ethypharm Ltd.
  • Eurand Pharmaceuticals Inc.
  • Elan Corp.
  • Johnson & Johnson, Ltd.
  • Nektar Therapeutics Ltd.
  • Bioject Inc.
  • Penwest Pharmaceuticals
  • Vectura Group Plc.
  • Durect Corp.
  • Labopharm Europe Ltd.
  • Skye Pharma Plc
  • Endo Pharmaceuticals Inc.
  • Flamel Technologies Inc.

Competitive Landscape

Key players competing in the global top 10 drug delivery technology market are Applied Pharma Ltd.; Alkermes Inc.; Nanopass Technologies Ltd.; Altea Therapeutics Inc.; Biovail Inc.; Paradigm Inc.; Ethypharm Ltd.; Eurand Pharmaceuticals Inc.; Elan Corp.; Johnson & Johnson, Ltd.; Nektar Therapeutics Ltd.; Bioject Inc.; Penwest Pharmaceuticals; Vectura Group Plc.; Durect Corp.; Labopharm Europe Ltd.; Skye Pharma Plc; Endo Pharmaceuticals Inc.; and Flamel Technologies Inc. The main market players are continuously engaged in various development activities such as mergers and acquisitions, research and developments, investments for innovative products and collaborations to have their competitive edge in the market.

Top 10 Drug Delivery Technology Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Technology Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Drug Delivery Technology Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Drug Delivery Technology Market - Supply Chain
  4.5. Global Drug Delivery Technology Market Forecast
     4.5.1. Drug Delivery Technology Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Drug Delivery Technology Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Drug Delivery Technology Market Absolute $ Opportunity
5. Global Drug Delivery Technology Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Drug Delivery Technology Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Drug Delivery Technology Demand Share Forecast, 2019-2026
6. North America Drug Delivery Technology Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Drug Delivery Technology Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Drug Delivery Technology Demand Share Forecast, 2019-2026
7. Latin America Drug Delivery Technology Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Drug Delivery Technology Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Drug Delivery Technology Demand Share Forecast, 2019-2026
8. Europe Drug Delivery Technology Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Drug Delivery Technology Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Drug Delivery Technology Demand Share Forecast, 2019-2026
9. Asia Pacific Drug Delivery Technology Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Drug Delivery Technology Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Drug Delivery Technology Demand Share Forecast, 2019-2026
10. Middle East & Africa Drug Delivery Technology Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Drug Delivery Technology Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Drug Delivery Technology Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Drug Delivery Technology Market: Market Share Analysis
  11.2. Drug Delivery Technology Distributors and Customers
  11.3. Drug Delivery Technology Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Applied Pharma Ltd.
     11.4.2. Alkermes Inc.
     11.4.3. Nanopass Technologies Ltd.
     11.4.4. Altea Therapeutics Inc.
     11.4.5. Biovail Inc.
     11.4.6. Paradigm Inc.
     11.4.7. Ethypharm Ltd.
     11.4.8. Eurand

Segments Covered in the Report

The global top 10 drug delivery technology market has been segmented on the basis of

Applications

  • Injectable
  • Sustained Release
  • Aerosol
  • Transdermal
  • Implants
  • Targeted Delivery
  • Pegylation
  • Encapsulation
  • Liposomal

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Applied Pharma Ltd.
  • Alkermes Inc.
  • Nanopass Technologies Ltd.
  • Altea Therapeutics Inc.
  • Biovail Inc.
  • Paradigm Inc.
  • Ethypharm Ltd.
  • Eurand Pharmaceuticals Inc.
  • Elan Corp.
  • Johnson & Johnson, Ltd.
  • Nektar Therapeutics Ltd.
  • Bioject Inc.
  • Penwest Pharmaceuticals
  • Vectura Group Plc.
  • Durect Corp.
  • Labopharm Europe Ltd.
  • Skye Pharma Plc
  • Endo Pharmaceuticals Inc.
  • Flamel Technologies Inc.

Key players competing in the global top 10 drug delivery technology market are Applied Pharma Ltd.; Alkermes Inc.; Nanopass Technologies Ltd.; Altea Therapeutics Inc.; Biovail Inc.; Paradigm Inc.; Ethypharm Ltd.; Eurand Pharmaceuticals Inc.; Elan Corp.; Johnson & Johnson, Ltd.; Nektar Therapeutics Ltd.; Bioject Inc.; Penwest Pharmaceuticals; Vectura Group Plc.; Durect Corp.; Labopharm Europe Ltd.; Skye Pharma Plc; Endo Pharmaceuticals Inc.; and Flamel Technologies Inc. The main market players are continuously engaged in various development activities such as mergers and acquisitions, research and developments, investments for innovative products and collaborations to have their competitive edge in the market.

Top 10 Drug Delivery Technology Market keyplayers

Buy Report